IMCR
Immunocore Holdings plcCompany with tickers: IMCR
CIK
1671927
CUSIP
45258D105
Shares Outstanding
50,865,574
Website
https://www.immunocore.com
Investor Relations
https://www.immunocore.com/investors
13F Activity (30d)
3 filings
2 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IMCR
55 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 1,179,792 | $38,107,282 | 0.05% | Long | 2026-02-28 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 643,368 | $19,397,545 | 0.18% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 500,000 | $16,150,000 | 0.26% | Long | 2026-02-28 | |
| T. Rowe Price Small-Cap Stock Fund, Inc. | — | 465,030 | $14,020,655 | 0.17% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 351,286 | $11,346,538 | 0.05% | Long | 2026-02-28 | |
| Select Biotechnology Portfolio | — | 321,500 | $10,384,450 | 0.19% | Long | 2026-02-28 | |
| MFS New Discovery Fund | — | 304,295 | $9,828,729 | 0.47% | Long | 2026-02-28 | |
| Fidelity Series Growth Company Fund | — | 291,070 | $9,401,561 | 0.04% | Long | 2026-02-28 | |
| T. Rowe Price Small-Cap Value Fund, Inc. | — | 296,284 | $8,932,963 | 0.10% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 277,185 | $8,357,128 | 0.10% | Long | 2026-03-31 | |
| T. Rowe Price Institutional Small-Cap Stock Fund | — | 264,520 | $7,975,278 | 0.18% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 188,691 | $6,094,719 | 0.09% | Long | 2026-02-27 | |
| MFS New Discovery Series | — | 102,016 | $3,075,782 | 0.43% | Long | 2026-03-31 | |
| VIP Health Care Portfolio | — | 84,000 | $2,532,600 | 0.25% | Long | 2026-03-31 | |
| abrdn Healthcare Investors | HQH | 66,916 | $2,017,517 | 0.18% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | — | 63,806 | $1,923,751 | 0.01% | Long | 2026-03-31 | |
| HUSSMAN STRATEGIC MARKET CYCLE FUND | — | 60,000 | $1,809,000 | 0.46% | Long | 2026-03-31 | |
| abrdn Life Sciences Investors | HQL | 49,941 | $1,505,721 | 0.27% | Long | 2026-03-31 | |
| ALPS Medical Breakthroughs ETF | — | 45,035 | $1,454,631 | 1.05% | Long | 2026-02-28 | |
| T. Rowe Price Health Sciences Portfolio | — | 39,016 | $1,176,332 | 0.18% | Long | 2026-03-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 37,226 | $1,122,364 | 0.11% | Long | 2026-03-31 | |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund | — | 33,089 | $1,068,775 | 0.03% | Long | 2026-02-28 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | — | 33,934 | $1,023,110 | 0.13% | Long | 2026-03-31 | |
| Tema Oncology ETF | — | 28,275 | $913,283 | 0.57% | Long | 2026-02-28 | |
| Fidelity Nasdaq Composite Index Fund | — | 25,502 | $823,715 | 0.00% | Long | 2026-02-28 | |
| Small Cap Value Portfolio | — | 26,553 | $800,573 | 0.14% | Long | 2026-03-31 | |
| Large-Cap Growth Portfolio | — | 25,052 | $755,318 | 0.06% | Long | 2026-03-31 | |
| SmallCap Account | — | 20,500 | $618,075 | 0.36% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 17,356 | $560,599 | 0.01% | Long | 2026-02-28 | |
| BlackRock Health Sciences Trust | BME | 16,565 | $499,435 | 0.09% | Long | 2026-03-31 | |
| Health Sciences Trust | — | 16,454 | $496,088 | 0.22% | Long | 2026-03-31 | |
| 1290 VT Micro Cap Portfolio | — | 13,700 | $413,055 | 0.24% | Long | 2026-03-31 | |
| T. Rowe Price Spectrum Moderate Allocation Fund | — | 11,423 | $368,963 | 0.02% | Long | 2026-02-28 | |
| HARTFORD HEALTHCARE HLS FUND | — | 12,125 | $365,569 | 0.35% | Long | 2026-03-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 11,527 | $347,539 | 0.22% | Long | 2026-03-31 | |
| Health Sciences Portfolio | — | 11,435 | $344,765 | 0.10% | Long | 2026-03-31 | |
| International Opportunities Fund | — | 10,104 | $326,359 | 0.09% | Long | 2026-02-28 | |
| T. Rowe Price Spectrum Conservative Allocation Fund | — | 7,351 | $237,437 | 0.01% | Long | 2026-02-28 | |
| Empower Small Cap Growth Fund | — | 5,912 | $178,247 | 0.08% | Long | 2026-03-31 | |
| Small Company Value Trust | — | 5,890 | $177,584 | 0.14% | Long | 2026-03-31 | |
| VIP Dynamic Capital Appreciation Portfolio | — | 5,700 | $171,855 | 0.06% | Long | 2026-03-31 | |
| AVIP Fidelity Institutional AM Equity Growth Portfolio | — | 5,130 | $154,670 | 0.07% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 4,500 | $135,675 | 0.00% | Long | 2026-03-31 | |
| Guardian Large Cap Fundamental Growth VIP Fund | — | 3,314 | $99,917 | 0.07% | Long | 2026-03-31 | |
| HUSSMAN STRATEGIC ALLOCATION FUND | — | 3,000 | $90,450 | 0.35% | Long | 2026-03-31 | |
| Invesco Nasdaq Biotechnology ETF | — | 2,432 | $78,554 | 0.10% | Long | 2026-02-28 | |
| T. Rowe Price Health Care ETF | — | 2,468 | $74,410 | 0.37% | Long | 2026-03-31 | |
| ProShares Ultra Nasdaq Biotechnology | — | 2,015 | $65,085 | 0.07% | Long | 2026-02-28 | |
| First Trust Small Cap BuyWrite Income ETF | — | 1,281 | $38,622 | 0.17% | Long | 2026-03-31 | |
| Small Company Growth Portfolio | — | 950 | $28,643 | 0.13% | Long | 2026-03-31 |
Showing 1–50 of 55 positions